Evaluation of liver and thyroid toxicity in Sprague-Dawley rats after exposure to polybrominated diphenyl ether BDE-209
-
- Lee Ena
- College of Pharmacy, Pusan National University
-
- Kim Tae Hyung
- College of Pharmacy, Pusan National University
-
- Choi Jae Seok
- College of Pharmacy, Pusan National University
-
- Nabanata Patra
- College of Pharmacy, Pusan National University
-
- Kim Na Young
- College of Pharmacy, Pusan National University
-
- Ahn Mee Young
- College of Pharmacy, Pusan National University
-
- Jung Ki Kyung
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Kang Il Hyun
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Kim Tae Sung
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Kwack Seung Jun
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Park Kui Lea
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Kim Seung Hee
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Kang Tae Seok
- National Institute of Toxicological Research, Korea Food and Drug Administration
-
- Lee Jaewon
- College of Pharmacy, Pusan National University
-
- Lee Byung Mu
- Division of Toxicology, College of Pharmacy, Sungkyunkwan University
-
- Kim Hyung Sik
- College of Pharmacy, Pusan National University
この論文をさがす
抄録
Our goal in the present study was to evaluate whether decabromodiphenyl ether (BDE-209), which is the most abundant polybrominated diphenyl ether (PBDE) found in human samples, affects against target organs. Sprague-Dawley male rats were exposed to vehicle or BDE-209 (100, 300, or 600 mg/kg body weight, daily) from postnatal day (PND) 10 to PND 42. There was no significant difference in body and male reproductive organ weight changes compared with controls. However, liver, thyroid and adrenal gland weights were significantly increased in the high-dose of BDE-209 group. BDE-209 significantly induced the expression of cytochrome P450 (CYP1A2, CYP3A1, and CYP2B1) enzymes in the liver. Furthermore, constitutive androstane receptor (CAR) and pregnane xenobiotic receptor (PXR) expression levels were also increased in a dose-dependent manner. Total serum triiodothyronine (T3) concentration was significantly reduced in a dose-dependent manner, whereas the level of thyroid-stimulating hormone was significantly increased with BDE-209 treatment. In the histological findings, multiple areas of degenerated follicular epithelium and slight attenuation of the follicular epithelium were observed in the thyroid glands by high doses (300 and 600 mg/kg) of BDE-209 treatment. The presence of hepatocytic fatty degeneration and inflammatory foci were also observed in the 300 and 600 mg/kg of BDE-209 group. These findings demonstrate that BDE-209 induces hyperthyroidism and hepatotoxicity. In the future, further research is needed to determine the relationship between target organ toxicity and blood concentrations of BDE-209.
収録刊行物
-
- The Journal of Toxicological Sciences
-
The Journal of Toxicological Sciences 35 (4), 535-545, 2010
一般社団法人 日本毒性学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679877909632
-
- NII論文ID
- 10026566814
-
- NII書誌ID
- AN00002808
-
- COI
- 1:CAS:528:DC%2BC3cXhtFahs7vM
-
- ISSN
- 18803989
- 03881350
-
- NDL書誌ID
- 10801415
-
- PubMed
- 20686340
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可